iBET researchers developed a new 3D cell culture model to study the impact of the immune microenvironment of solid tumours in tumour progression and therapeutic response. Cancer drug discovery has been limited by high rates of failure in clinical trials, despite positive laboratory tests suggesting good drug activity. Several types of tumour cell models are used in research labs and by the pharmaceutical industry for discovery and pre-clinical testing of new anti-cancer drugs.
